We reported previously that the majority of high-grade human NE tumors expressed high levels of NFIB, highlighting the relevance of the RPF mouse model for understanding SCLC behavior in patients (Semenova et al., 2016). This evidence concerns the gene NFIB and small cell lung carcinoma.